Thu, February 22, 2018
Wed, February 21, 2018
Tue, February 20, 2018

Paul Matteis Maintained (WVE) at Buy with Increased Target to $64 on, Feb 21st, 2018

Paul Matteis of Leerink Swann, Maintained "Wave Life Sciences Ltd." (WVE) at Buy with Increased Target from $53 to $64 on, Feb 21st, 2018.

Paul, nor any peers, have made any analyst calls on WVE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30